Efficacy of the Cosmetic Product "Onco-Repair" on Grade 2 Hand Foot Syndrome

Inclusion Criteria: * Who suffers from grade 2 HFS * Subject under anti-tumor treatment known to cause this toxicity: targeted therapies or conventional chemotherapy: 5-Fluorouracile, Aflibercept, Axitinib, Bévacizumab, Capécitabine, Cediranib, Cytarabine, Dabrafenib, Docétaxel, Doxorubicine, Epirubicine, Pazopanib, Sorafenib, Sunitinib, Trastuzumab, Regorafenib, Vemurafenib and any other anti-tumor treatment that may lead to this toxicity * Subject 18 years old and more * Subject having been informed, having signed a free, informed and written consent * Woman of childbearing age using contraception deemed effective Non-Inclusion Criteria: * Pregnant or lactating women * Subject having a history of allergic contact dermatitis or irritation to any of the components of the investigational products * Subjects with another skin pathology that may interfere with the evaluation of a HFS (at the investigator's discretion) * Subject under anti-inflammatory treatment * Subject participating in another clinical study during the duration of the study, except in a study assessing one of the molecules listed in the section above * Subject who has already been treated for Grade 2 HFS or under other local treatment or cosmetic product * Subject refusing to interrupt the application of his/her usual care * Subject having a strongly altered general condition and / or non-autonomous subject (Karnofsky index \<50%) * Subject in linguistic or psychic impossibility to understand and sign infor…